Corradini Paolo
Full professor
SSD
MED/15 - BLOOD DISEASES
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY
Research fields and competencies
Contacts
Workplace
Additional phone numbers
University email address
Teaching - Programme courses
Bachelors and masters
A.Y. 2020/2021
A.Y. 2019/2020
A.Y. 2018/2019
A.Y. 2017/2018
A.Y. 2016/2017
Postgraduate programmes
A.Y. 2020/2021
1st level vocational master
- Metodologia clinica oncologica (Master in management degli studi clinici in oncologia ed emato-oncologia - primo livello)
A.Y. 2018/2019
Doctoral programme (PhD)
1st level vocational master
- Metodologia clinica oncologica (Master in management degli studi clinici in oncologia ed emato-oncologia - primo livello)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Malattie del sangue (Postgraduate School of Medical Oncology)
- Malattie del sangue 1 (Postgraduate School of Hematology)
- Malattie del sangue 2 (Postgraduate School of Hematology)
- Malattie del sangue 3 (Postgraduate School of Hematology)
- Malattie del sangue 4 (Postgraduate School of Hematology)
- Malattie del sangue 5 (Postgraduate School of Hematology (OLD))
- Malattie del sangue tronco comune (Postgraduate School of Hematology (OLD))
- Malattie del sangue tronco comune (Postgraduate School of Cardiovascular Diseases (OLD))
- Ricerca clinica e preparazione scientifica (PRIMO ANNO) (Postgraduate School of Hematology)
- Ricerca clinica e preparazione scientifica (QUARTO ANNO) (Postgraduate School of Hematology)
- Ricerca clinica e preparazione scientifica (SECONDO ANNO) (Postgraduate School of Hematology)
- Ricerca clinica e preparazione scientifica (TERZO ANNO) (Postgraduate School of Hematology)
Research
Publications
Publications
-
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study / F. Passamonti, C. Cattaneo, L. Arcaini, R. Bruna, M. Cavo, F. Merli, E. Angelucci, M. Krampera, R. Cairoli, M.G. Della Porta, N. Fracchiolla, M. Ladetto, C. Gambacorti Passerini, M. Salvini, M. Marchetti, R. Lemoli, A. Molteni, A. Busca, A. Cuneo, A. Romano, N. Giuliani, S. Galimberti, A. Corso, A. Morotti, B. Falini, A. Billio, F. Gherlinzoni, G. Visani, M.C. Tisi, A. Tafuri, P. Tosi, F. Lanza, M. Massaia, M. Turrini, F. Ferrara, C. Gurrieri, D. Vallisa, M. Martelli, E. Derenzini, A. Guarini, A. Conconi, A. Cuccaro, L. Cudillo, D. Russo, F. Ciambelli, A.M. Scattolin, M. Luppi, C. Selleri, E. Ortu La Barbera, C. Ferrandina, N. Di Renzo, A. Olivieri, M. Bocchia, M. Gentile, F. Marchesi, P. Musto, A.B. Federici, A. Candoni, A. Venditti, C. Fava, A. Pinto, P. Galieni, L. Rigacci, D. Armiento, F. Pane, M. Oberti, P. Zappasodi, C. Visco, M. Franchi, P.A. Grossi, L. Bertu, G. Corrao, L. Pagano, P. Corradini. - In: THE LANCET. HAEMATOLOGY. - ISSN 2352-3026. - 7:10(2020 Oct), pp. e737-e745.
-
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk / K. Weisel, A. Spencer, S. Lentzsch, H. Avet-Loiseau, T.M. Mark, I. Spicka, T. Masszi, B. Lauri, M.D. Levin, A. Bosi, V. Hungria, M. Cavo, J.J. Lee, A. Nooka, H. Quach, M. Munder, C. Lee, W. Barreto, P. Corradini, C.K. Min, A.A. Chanan-Khan, N. Horvath, M. Capra, M. Beksac, R. Ovilla, J.C. Jo, H.J. Shin, P. Sonneveld, T. Casneuf, N. DeAngelis, H. Amin, J. Ukropec, R. Kobos, M.V. Mateos. - In: JOURNAL OF HEMATOLOGY & ONCOLOGY. - ISSN 1756-8722. - 13:1(2020 Aug 20), pp. 115.1-115.11.
-
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) / S. Salmoiraghi, R. Cavagna, P. Zanghi', C. Pavoni, A. Michelato, K. Buklijas, L. Elidi, T. Intermesoli, F. Lussana, E. Oldani, C. Caprioli, P. Stefanoni, G. Gianfaldoni, E. Audisio, E. Terruzzi, L. De Paoli, E. Borlenghi, I. Cavattoni, D. Mattei, A. Scattolin, M. Tajana, F. Ciceri, E. Todisco, L. Campiotti, P. Corradini, N. Fracchiolla, R. Bassan, A. Rambaldi, O. Spinelli. - In: CANCERS. - ISSN 2072-6694. - 12:8(2020 Aug 11), pp. 2242.1-2242.14.
-
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase / C. Oltolini, A. Guidetti, M. Ripa, B. Castiglioni, C. Tassan Din, S. Mastaglio, D. Canetti, G. Monti, A. Andolina, C. Molinari, A. Poloniato, A. Mastrangelo, M. Ferrante, M. Lanzillotta, P. Scarpellini, A. Castagna, P. Corradini, F. Ciceri. - In: HEMASPHERE. - ISSN 2572-9241. - 4:4(2020 Aug), pp. e448.1-e448.4.
-
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma : Three-year Follow-up of CASTOR / M.-. Mateos, P. Sonneveld, V. Hungria, A.K. Nooka, J.A. Estell, W. Barreto, P. Corradini, C.-. Min, E. Medvedova, K. Weisel, C. Chiu, J.M. Schecter, H. Amin, X. Qin, J. Ukropec, R. Kobos, A. Spencer. - In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - ISSN 2152-2650. - 20:8(2020 Aug), pp. 509-518.